Cell therapy for advanced pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial tests a new cell therapy (BGT007H) for people with advanced pancreatic cancer that has not responded to earlier treatments. The goal is to see if it is safe and can help shrink or control the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 75 years old.
- You have advanced pancreatic cancer that has not responded to or come back after at least two standard treatments.
- You are generally well enough to be up and about (ECOG score 0 or 1).
- Your blood counts, liver, and kidney function are within safe limits.
- You are willing to use effective birth control during and for 6 months after the treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new kind of immunotherapy for pancreatic cancer that has not been removed by surgery or has spread. It aims to see if the treatment can help shrink or control the cancer, and you may be eligible whether you have had previous chemotherapy or not.
This study tests a new drug (MRG004A) for advanced pancreatic cancer that has not responded to earlier treatments. The drug is given together with best supportive care (treatments to manage symptoms), and compared to a placebo (a dummy treatment) with best supportive care. The goal is to see if the new drug can slow down the cancer and help you live longer.
This early-stage trial tests a new drug called ES502 for patients with advanced cancers (including pancreatic cancer) that have a specific genetic mutation and certain immune markers. The study aims to find the right dose and see if it helps shrink tumors.
This trial tests an experimental cell therapy called BGT007 for people with advanced pancreatic or colorectal cancer that has not responded to standard treatments. The therapy uses your own immune cells, which are collected, modified, and given back to you to fight the cancer.
This trial tests a new immune cell therapy (EGFRBi armed PBMC) for people with advanced pancreatic cancer that can't be removed by surgery. It aims to see if this treatment can help control the cancer after you've already tried at least one type of chemotherapy and your disease is stable or better.
This trial tests an experimental cell therapy called MT-601 for pancreatic cancer that is advanced. The treatment uses your own immune cells to fight the cancer, and the goal is to see if it is safe and helps people whose cancer is stable or shrinking on chemotherapy.
Hear when a new Tumor Pancreas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.